Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Allogeneic Transplant Following Brentuximab Vedotin Treatment in Patients with Relapsed or Refractory CD30+Lymphomas 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Illidge, T., Bouabdallah, R., Chen, R. W., Gopal, A. K., Moskowitz, C. H., Ramchandren, R., Rosenblatt, J. D., Shustov, A. R., Tilly, H., Trippett, T., Grove, L. E., Advani, R. H. AMER SOC HEMATOLOGY. 2011: 1335–36
View details for Web of Science ID 000299597104442